Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice

eLife

Volumn 2013, Issue 2, 2013, Pages

  Sun, Liou Y ^a   Spong, Adam ^a   Swindell, William R ^b   Fang, Yimin ^a   Hill, Cristal ^a   Huber, Joshua A ^a   Boehm, Jacob D ^a   Westbrook, Reyhan ^a   Salvatori, Roberto ^c   Bartke, Andrzej ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOCHROME P450; DRUG THERAPY; GROWTH HORMONE RELEASING FACTOR; HEPATOCYTE NUCLEAR FACTOR; NFE2L2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; XENOBIOTIC AGENT;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CALORIC RESTRICTION; CALORIMETRY; CONTROLLED STUDY; DETOXIFICATION; DRUG THERAPY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HYPOPITUITARISM; INFLAMMATION; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; LIVER; LONGEVITY; MALE; METABOLIC REGULATION; METABOLISM; MICROARRAY ANALYSIS; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; PHENOTYPE; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRESS; WESTERN BLOTTING;

ANIMALS; CALORIC RESTRICTION; DRUG THERAPY; GENE EXPRESSION PROFILING; GENETICS; GROWTH HORMONE-RELEASING HORMONE; HYPOPITUITARISM; LIVER; LONGEVITY; METABOLISM; MICE; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; PHENOTYPE; PHYSIOLOGY; THERAPEUTIC USE; XENOBIOTICS;

MUS;

EID: 84887366856     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/elife.01098     Document Type: Article

References (59)

1. Alba M, Salvatori R. 2004. A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency. Endocrinology 145:4134-43. doi: 10.1210/en.2004-0119.
2. Amador-Noguez D, Dean A, Huang W, Setchell K, Moore D, Darlington G. 2007. Alterations in xenobiotic metabolism in the long-lived Little mice. Aging Cell 6:453-70. doi: 10.1111/j.1474-9726.2007.00300.x.
3. Amador-Noguez D, Yagi K, Venable S, Darlington G. 2004. Gene expression profile of long-lived Ames dwarf mice and Little mice. Aging Cell 3:423-41. doi: 10.1111/j.1474-9728.2004.00125.x.
4. Anwar-Mohamed A, Degenhardt OS, El Gendy MA, Seubert JM, Kleeberger SR, El-Kadi AO. 2011. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers. Toxicol In Vitro 25:785-95. doi: 10.1016/j.tiv.2011.01.014.
5. Bartke A. 2011. Single-gene mutations and healthy ageing in mammals. Philos Trans R Soc Lond B Biol Sci 366:28-34. doi: 10.1098/rstb.2010.0281.
6. Bartke A, Sun LY, Longo V. 2013. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol Rev 93:571-98. doi: 10.1152/physrev.00006.2012.
7. Bartke A, Wright JC, Mattison JA, Ingram DK, Miller RA, Roth GS. 2001. Extending the lifespan of long-lived mice. Nature 414:412. doi: 10.1038/35106646.
8. Bonkowski MS, Rocha JS, Masternak MM, Al Regaiey KA, Bartke A. 2006. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc Natl Acad Sci USA 103:7901-5. doi: 10.1073/pnas.0600161103.
9. Boylston WH, DeFord JH, Papaconstantinou J. 2006. Identification of longevity-associated genes in long-lived Snell and Ames dwarf mice. Age (Dordr) 28:125-44. doi: 10.1007/s11357-006-9008-6.
10. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. 1996. Dwarf mice and the ageing process. Nature 384:33. doi: 10.1038/384033a0.
11. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. 2003. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144:3799-810. doi: 10.1210/en.2003-0374.
12. Eicher EM, Beamer WG. 1976. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. J Hered 67:87-91.
13. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. 2001. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98:6736-41. doi: 10.1073/pnas.111158898.
14. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE. 1993. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-32. doi: 10.1038/ng0793-227.
15. Hwa V, Oh Y, Rosenfeld RG. 1999. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761-87. doi: 10.1210/er.20.6.761.
16. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. 2003. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci 58:291-6. doi: 10.1093/gerona/58.4.B291.
17. Ikeno Y, Hubbard GB, Lee S, Cortez LA, Lew CM, Webb CR, et al. 2009. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J Gerontol A Biol Sci Med Sci 64:522-9. doi: 10.1093/gerona/glp017.
18. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. 2008. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 8:77-83. doi: 10.1016/j.cmet.2008.05.006.
19. Johnston CS, Tjonn SL, Swan PD, White A, Hutchins H, Sears B. 2006. Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. Am J Clin Nutr 83:1055-61.
20. Kenyon CJ. 2010. The genetics of ageing. Nature 464:504-12. doi: 10.1038/nature08980.
21. Kobori M, Masumoto S, Akimoto Y, Takahashi Y. 2009. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res 53:859-68. doi: 10.1002/mnfr.200800310.
22. List EO, Sackmann-Sala L, Berryman DE, Funk K, Kelder B, Gosney ES, et al. 2011. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr Rev 32:356-86. doi: 10.1210/er.2010-0009.
23. Ma Q. 2013. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401-26. doi: 10.1146/annurev-pharmtox-011112-140320.
24. McElwee JJ, Schuster E, Blanc E, Thomas JH, Gems D. 2004. Shared transcriptional signature in Caenorhabditis elegans Dauer larvae and long-lived daf-2 mutants implicates detoxification system in longevity assurance. J Biol Chem 279:44533-43. doi: 10.1074/jbc.M406207200.
25. Miller RA. 2009. Cell stress and aging: new emphasis on multiplex resistance mechanisms. J Gerontol A Biol Sci Med Sci 64:179-82. doi: 10.1093/gerona/gln072.
26. Noale M, Maggi S, Zanoni S, Limongi F, Zambon S, Crepaldi G. 2012. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing. Diabetes Metab 38:135-41. doi: 10.1016/j.diabet.2011.09.005.
27. Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M. 2006. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 339:79-88. doi: 10.1016/j.bbrc.2005.10.185.
28. Osterreicher CH, Trauner M. 2012. Xenobiotic-induced liver injury and fibrosis. Expert Opin Drug Metab Toxicol 8:571-80. doi: 10.1517/17425255.2012.674511.
29. Panici JA, Harper JM, Miller RA, Bartke A, Spong A, Masternak MM. 2010. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB J 24:5073-9. doi: 10.1096/fj.10-163253.
30. Paolisso G, Gambardella A, Ammendola S, D'Amore A, Balbi V, Varricchio M, et al. 1996. Glucose tolerance and insulin action in healthy centenarians. Am J Physiol 270:E890-4.
31. Potthoff MJ, Kliewer SA, Mangelsdorf DJ. 2012. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev 26:312-24. doi: 10.1101/gad.184788.111.
32. Rogers AB, Theve EJ, Feng Y, Fry RC, Taghizadeh K, Clapp KM, et al. 2007. Hepatocellular carcinoma associated with liver-gender disruption in male mice. Cancer Res 67:11536-46. doi: 10.1158/0008-5472.CAN-07-1479.
33. Rowland JE, Lichanska AM, Kerr LM, White M, d'Aniello EM, Maher SL, et al. 2005. In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol 25:66-77. doi: 10.1128/MCB.25.1.66-77.2005.
34. Selman C, Lingard S, Choudhury AI, Batterham RL, Claret M, Clements M, et al. 2008. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J 22:807-18. doi: 10.1096/fj.07-9261com.
35. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, et al. 2009. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326:140-4. doi: 10.1126/science.1177221.
36. Sharma N, Castorena CM, Cartee GD. 2012. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines. Nutr Metab (Lond) 9:90. doi: 10.1186/1743-7075-9-90.
37. Sharp ZD, Bartke A. 2005. Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice. J Gerontol A Biol Sci Med Sci 60:293-300. doi: 10.1093/gerona/60.3.293.
38. Shore DE, Carr CE, Ruvkun G. 2012. Induction of cytoprotective pathways is central to the extension of lifespan conferred by multiple longevity pathways. PLOS Genet 8:e1002792. doi: 10.1371/journal.pgen.1002792.
39. Steinbaugh MJ, Sun LY, Bartke A, Miller RA. 2012. Activation of genes involved in xenobiotic metabolism is a shared signature of mouse models with extended lifespan. Am J Physiol Endocrinol Metab 303:E488-95. doi: 10.1152/ajpendo.00110.2012.
40. Stensvold D, Nauman J, Nilsen TI, Wisloff U, Slordahl SA, Vatten L. 2011. Even low level of physical activity is associated with reduced mortality among people with metabolic syndrome, a population based study (the HUNT 2 study, Norway). BMC Med 9:109. doi: 10.1186/1741-7015-9-109.
41. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A. 2005. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging 26:929-37. doi: 10.1016/j.neurobiolaging.2004.07.010.
42. Sun LY, Bokov AF, Richardson A, Miller RA. 2011. Hepatic response to oxidative injury in long-lived Ames dwarf mice. FASEB J 25:398-408. doi: 10.1096/fj.10-164376.
43. Swindell WR. 2009. Accelerated failure time models provide a useful statistical framework for aging research. Exp Gerontol 44:190-200. doi: 10.1016/j.exger.2008.10.005.
44. Swindell WR. 2012. Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan. Ageing Res Rev 11:254-70. doi: 10.1016/j.arr.2011.12.006.
45. Swindell WR, Johnston A, Sun L, Xing X, Fisher GJ, Bulyk ML, et al. 2012. Meta-profiles of gene expression during aging: limited similarities between mouse and human and an unexpectedly decreased inflammatory signature. PLOS ONE 7:e33204. doi: 10.1371/journal.pone.0033204.
46. Swindell WR, Johnston A, Xing X, Little A, Robichaud P, Voorhees JJ, et al. 2013. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Sci Rep 3:1215. doi: 10.1038/srep01215.
47. Sykiotis GP, Bohmann D. 2008. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell 14:76-85. doi: 10.1016/j.devcel.2007.12.002.
48. Tatar M, Bartke A, Antebi A. 2003. The endocrine regulation of aging by insulin-like signals. Science 299:1346-51. doi: 10.1126/science.1081447.
49. Tullet JM, Hertweck M, An JH, Baker J, Hwang JY, Liu S, et al. 2008. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132:1025-38. doi: 10.1016/j.cell.2008.01.030.
50. Um SH, D'Alessio D, Thomas G. 2006. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3:393-402. doi: 10.1016/j.cmet.2006.05.003.
51. Vergara M, Smith-Wheelock M, Harper JM, Sigler R, Miller RA. 2004. Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. J Gerontol A Biol Sci Med Sci 59:1244-50. doi: 10.1093/gerona/59.12.1244.
52. Wang C, Li Q, Redden DT, Weindruch R, Allison DB. 2004. Statistical methods for testing effects on maximum lifespan. Mech Ageing Dev 125:629-32. doi: 10.1016/j.mad.2004.07.003.
53. Waxman DJ, Holloway MG. 2009. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76:215-28. doi: 10.1124/mol.109.056705.
54. Weindruch R, Sohal RS. 1997. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 337:986-94. doi: 10.1056/NEJM199710023371407.
55. Westbrook R, Bonkowski MS, Strader AD, Bartke A. 2009. Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice. J Gerontol A Biol Sci Med Sci 64:443-51. doi: 10.1093/gerona/gln075.
56. Wu KC, Cui JY, Klaassen CD. 2012. Effect of graded Nrf2 activation on phase-I and-II drug metabolizing enzymes and transporters in mouse liver. PLOS ONE 7:e39006. doi: 10.1371/journal.pone.0039006.
57. Yates MS, Tran QT, Dolan PM, Osburn WO, Shin S, McCulloch CC, et al. 2009. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 30:1024-31. doi: 10.1093/carcin/bgp100.
58. Zhang Y, Xie Y, Berglund ED, Coate KC, He TT, Katafuchi T, et al. 2012. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. eLife 1:e00065. doi: 10.7554/eLife.00065.
59. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, et al. 1990. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 259:E650-7.